{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:56:45Z","timestamp":1790121405644,"version":"4.0.1"},"reference-count":58,"publisher":"American Chemical Society (ACS)","issue":"7","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Chem. Res. Toxicol."],"published-print":{"date-parts":[[1996,1,1]]},"DOI":"10.1021\/tx960083q","type":"journal-article","created":{"date-parts":[[2002,7,26]],"date-time":"2002-07-26T05:30:15Z","timestamp":1027661415000},"page":"1159-1166","source":"Crossref","is-referenced-by-count":169,"title":["Human Cytochrome P450 2E1 Is a Major Autoantigen Associated with Halothane Hepatitis"],"prefix":"10.1021","volume":"9","author":[{"given":"Mohammed","family":"Bourdi","sequence":"first","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiqiao","family":"Chen","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raimund M.","family":"Peter","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie L.","family":"Martin","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen T. M.","family":"Buters","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sidney D.","family":"Nelson","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lance R.","family":"Pohl","sequence":"additional","affiliation":[{"name":"Molecular and Cellular Toxicology Section, Laboratory of Molecular Immunology, National Heart, Lung, and Blood Institute, National Institutes of Health, Bethesda, Maryland 20892, Department of Medicinal Chemistry, University of Washington, Seattle, Washington 98195, The Department of Anesthesiology and Critical Care Medicine, The Johns Hopkins Medical Institutions, Baltimore, Maryland 21287, and Laboratory of Molecular Carcinogenesis, National Cancer Institute, National Institutes of Health, Bethesda,..."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"316","published-online":{"date-parts":[[1996,10,15]]},"reference":[{"key":"tx960083qb00001\/tx960083qb00001_1","volume-title":"Drug-induced allergic hepatitis. Semin. Liver Dis. 10, 305\u2212315","author":"Pohl L. R.","year":"1990"},{"key":"tx960083qb00002\/tx960083qb00002_1","doi-asserted-by":"crossref","DOI":"10.1042\/bst0190191","volume":"19","author":"Kenna J. G.","year":"1991","journal-title":"Biochem. Soc. Trans."},{"key":"tx960083qb00003\/tx960083qb00003_1","volume-title":"Hepatotoxicity after desflurane anesthesia. Anesthesiology 83 (5), 1125\u22121129","author":"Martin J. L.","year":"1995"},{"key":"tx960083qb00004\/tx960083qb00004_1","doi-asserted-by":"crossref","DOI":"10.1016\/0014-2999(90)94224-L","volume":"183","author":"Thomassen D.","year":"1990","journal-title":"Eur. J. Pharmacol."},{"key":"tx960083qb00005\/tx960083qb00005_1","first-page":"255","volume":"12","author":"Davila J. C.","year":"1992","journal-title":"Toxicologist"},{"key":"tx960083qb00006\/tx960083qb00006_1","volume-title":"Serum antibodies from halothane hepatitis patients react with the rat endoplasmic reticulum protein ERp72. Chem. Res. Toxicol. 6, 609\u2212615","author":"Pumford N. R.","year":"1993"},{"key":"tx960083qb00007\/tx960083qb00007_1","volume-title":"The calcium-binding protein calreticulin is covalently modified in rat liver by a reactive metabolite of the inhalation anesthetic halothane. Chem. Res. Toxicol. 5, 406\u2212410. 1165","author":"Butler L. E.","year":"1992"},{"key":"tx960083qb00008\/tx960083qb00008_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 86","author":"Satoh H.","year":"1989"},{"key":"tx960083qb00009\/tx960083qb00009_1","doi-asserted-by":"crossref","unstructured":"Bourdi, M., Demady, D., Martin, J. L., Jabbour, S., Martin, B., George, J., and Pohl, L. R. (1995) cDNA cloning and baculovirus expression of the human liver endoplasmic reticulum P58:\u2009 characterization as a protein disulfide isomerase isoform, but not as a protease or a carnitine acyltransferase.Arch. Biochem. Biophys.323, 397\u2212403.","DOI":"10.1006\/abbi.1995.0060"},{"key":"tx960083qb00010\/tx960083qb00010_1","volume-title":"Halothane hepatitis patients have serum antibodies that react with protein disulfide isomerase. Hepatology 18, 858\u2212863","author":"Martin J. L.","year":"1993"},{"key":"tx960083qb00011\/tx960083qb00011_1","volume":"20","author":"Pohl L. R.","year":"1989","journal-title":"Drug. Metab. Rev."},{"key":"tx960083qb00012\/tx960083qb00012_1","volume-title":"Association of anti-58 kDa endoplasmic reticulum antibodies with halothane hepatitis. Biochem. Pharmacol. 46, 1247\u22121250","author":"Martin J. L.","year":"1993"},{"key":"tx960083qb00013\/tx960083qb00013_1","volume-title":"Autoantibodies to hepatic microsomal carboxylesterase in halothane hepatitis. Lancet 342, 963\u2212964","author":"Smith G. C. M.","year":"1993"},{"key":"tx960083qb00014\/tx960083qb00014_1","doi-asserted-by":"crossref","unstructured":"Frey, N., Christen, U., Jeno, P., Yeaman, S. J., Shimomura, Y., Kenna, J. G., Gandolfi, A. J., Ranek, L., and Gut, J. (1995) The lipoic acid containing components of the 2-oxoacid dehydrogenase complexes mimic trifluoroacetylated proteins and are autoantigens associated with halothane hepatitis.Chem. Res. Toxicol.8, 736\u2212746.","DOI":"10.1021\/tx00047a014"},{"key":"tx960083qb00015\/tx960083qb00015_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-2125.1995.tb04560.x","volume":"40","author":"Kitteringham N. R.","year":"1995","journal-title":"Br. J. Clin. Pharmacol."},{"key":"tx960083qb00016\/tx960083qb00016_1","volume-title":"Identification of the enzyme responsible for oxidative halothane metabolism:\u2009 implications for prevention of halothane hepatitis. Lancet 347, 1367\u22121371","author":"Kharasch E. D.","year":"1996"},{"key":"tx960083qb00017\/tx960083qb00017_1","volume-title":"Hydroxylation of chlorzoxazone as a specific probe for human liver cytochrome P450IIE1. Chem. Res. Toxicol. 3, 566\u2212573","author":"Peter R.","year":"1990"},{"key":"tx960083qb00018\/tx960083qb00018_1","volume":"233","author":"Satoh H.","year":"1985","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx960083qb00019\/tx960083qb00019_1","volume-title":"cDNA-directed expression of human cytochrome P450 CYP3A4 using baculovirus. Drug. Metab. Dispos. 22, 688\u2212692","author":"Buters J. T. M.","year":"1994"},{"key":"tx960083qb00020\/tx960083qb00020_1","volume":"264","author":"Shen A. L.","year":"1989","journal-title":"J. Biol. Chem."},{"key":"tx960083qb00021\/tx960083qb00021_1","volume-title":"The high level expression in Escherichia coli of the membrane-bound form of human and rat cytochrome b5 and studies on their mechanism of function. Arch. Biochem. Biophys. 312, 554\u2212565","author":"Holsman P. L.","year":"1994"},{"key":"tx960083qb00022\/tx960083qb00022_1","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/0006-2952(85)90104-2","volume":"34","author":"Kling L.","year":"1985","journal-title":"Biochem. Pharmacol."},{"key":"tx960083qb00023\/tx960083qb00023_1","volume-title":"Fractionation of liver microsomes with polyethylene glycol and purification of NADP\u2212cytochrome b5 oxidoreductase and cytochrome b5. Arch. Biochem. Biophys. 315, 438\u2212444","author":"Yang M. X.","year":"1994"},{"key":"tx960083qb00024\/tx960083qb00024_1","volume-title":"Human liver microsomal enflurane defluorination catalyzed by cytochrome P-450 2E1. Drug. Metab. Dispos. 21, 350\u2212357","author":"Thummel K. E.","year":"1993"},{"key":"tx960083qb00025\/tx960083qb00025_1","doi-asserted-by":"crossref","DOI":"10.1093\/bja\/59.10.1286","volume":"59","author":"Kenna J. G.","year":"1987","journal-title":"Br. J. Anaesth."},{"key":"tx960083qb00026\/tx960083qb00026_1","volume-title":"Antibody assays for the detection of patients sensitized to halothane. Anesth. Analg. 70, 154\u2212159","author":"Martin J. L.","year":"1990"},{"key":"tx960083qb00027\/tx960083qb00027_1","volume-title":"Processing of endoplasmic reticulum luminal antigens associated with halothane hepatitis in rat hepatocytes. Hepatology 22, 936\u2212943","author":"Amouzedeh H.","year":"1995"},{"key":"tx960083qb00028\/tx960083qb00028_1","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/dna.1988.7.79","volume":"7","author":"Gonzalez F. J.","year":"1988","journal-title":"DNA"},{"key":"tx960083qb00029\/tx960083qb00029_1","volume-title":"Autoantibodies against cytochrome P450:\u2009 role in human diseases. Adv. Pharmacol. 40, 199\u2212245","author":"Beaune P. H.","year":"1994"},{"key":"tx960083qb00030\/tx960083qb00030_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 85","author":"Zanger U. M.","year":"1988"},{"key":"tx960083qb00031\/tx960083qb00031_1","volume-title":"Identification of cytochrome P450 1A2 as a human autoantigen. Arch. Biochem. Biophy. 280, 229\u2212232","author":"Manns M. P.","year":"1990"},{"key":"tx960083qb00032\/tx960083qb00032_1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/0014-5793(92)80737-2","volume":"309","author":"Bednarek J.","year":"1992","journal-title":"FEBS Lett."},{"key":"tx960083qb00033\/tx960083qb00033_1","volume":"78","author":"Uibo R.","year":"1994","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"tx960083qb00034\/tx960083qb00034_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 84","author":"Beaune P. H.","year":"1987"},{"key":"tx960083qb00035\/tx960083qb00035_1","doi-asserted-by":"crossref","DOI":"10.1172\/JCI114660","volume":"85","author":"Bourdi M.","year":"1990","journal-title":"J. Clin. Invest."},{"key":"tx960083qb00036\/tx960083qb00036_1","volume-title":"Conformational epitopes on CYP2D6 are recognized by liver\/kidney microsomal antibodies. Gastroenterology 108, 470\u2212476","author":"Duclos-Vallee J. C.","year":"1995"},{"key":"tx960083qb00037\/tx960083qb00037_1","volume-title":"Autoantibodies to BCOADC-E2 in patients with primary biliary cirrhosis recognize a conformational epitope. Hepatology 22, 505\u2212513","author":"Leung P. S.","year":"1995"},{"key":"tx960083qb00038\/tx960083qb00038_1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1006\/clin.1994.1051","volume":"71","author":"Tuomi T.","year":"1994","journal-title":"Clin. Immunol. Immunopathol."},{"key":"tx960083qb00039\/tx960083qb00039_1","doi-asserted-by":"crossref","DOI":"10.1016\/0896-8411(91)90180-K","volume":"4","author":"Gueguen M.","year":"1991","journal-title":"J. Autoimmun."},{"key":"tx960083qb00040\/tx960083qb00040_1","volume-title":"Autoimmune disease and molecular mimicry:\u2009 an hypothesis. Trends Biochem. Sci. 18, 140\u2212144","author":"Baum H.","year":"1993"},{"key":"tx960083qb00041\/tx960083qb00041_1","volume-title":"B cell activation, tolerance and antigen-presenting function. Curr. Opin. Immunol. 7, 121\u2212129","author":"Hodgkin P. D.","year":"1995"},{"key":"tx960083qb00042\/tx960083qb00042_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 89","author":"Haba S.","year":"1992"},{"key":"tx960083qb00043\/tx960083qb00043_1","volume-title":"Induction of self-tolerance in T cells but not B cells of transgenic mice expressing little self antigen. Science 251, 1223\u22121225","author":"Adelstein S.","year":"1991"},{"key":"tx960083qb00044\/tx960083qb00044_1","volume":"121","author":"Weigle W. O.","year":"1964","journal-title":"J. Exp. Med."},{"key":"tx960083qb00045\/tx960083qb00045_1","doi-asserted-by":"crossref","DOI":"10.1084\/jem.119.3.425","volume":"119","author":"Deodhar S. D.","year":"1964","journal-title":"J. Exp. Med."},{"key":"tx960083qb00046\/tx960083qb00046_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 84","author":"Haba S.","year":"1987"},{"key":"tx960083qb00047\/tx960083qb00047_1","volume-title":"Autoimmunity and Toxicology","author":"Allison A. C.","year":"1989"},{"key":"tx960083qb00048\/tx960083qb00048_1","doi-asserted-by":"crossref","DOI":"10.1002\/eji.1830240343","volume":"24","author":"Steinhoff U.","year":"1994","journal-title":"Eur. J. Immunol."},{"key":"tx960083qb00049\/tx960083qb00049_1","doi-asserted-by":"crossref","unstructured":"Lecoeur, S., Bonierbale, E., Chaline, D., Gautier, J. C., Valadon, P., Dansette, P. M., Catinot, R., Ballet, F., Mansuy, D., and Beaune, P. H. (1994) Specificity of in vitro covalent binding of tienilic acid metabolites to human liver microsomes in relationship to the type of hepatotoxicity:\u2009 comparison with two directly hepatotoxic drugs.Chem. Res. Toxicol.7, 434\u2212442. 1166","DOI":"10.1021\/tx00039a023"},{"key":"tx960083qb00050\/tx960083qb00050_1","volume-title":"Metabolic activation of dihydralazine by P450 IA2 and its possible implication in triggering of dihydralazine induced hepatitis. Mol. Pharmacol. 45, 1287\u22121295","author":"Bourdi M.","year":"1994"},{"key":"tx960083qb00051\/tx960083qb00051_1","volume":"245","author":"Kenna J. G.","year":"1988","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"tx960083qb00052\/tx960083qb00052_1","volume-title":"Proc. Natl. Acad. Sci. U.S.A. 92","author":"Bhol K.","year":"1995"},{"key":"tx960083qb00053\/tx960083qb00053_1","doi-asserted-by":"crossref","DOI":"10.1111\/j.1365-3083.1995.tb03637.x","volume":"42","author":"Saalman R.","year":"1995","journal-title":"Scand. J. Immunol."},{"key":"tx960083qb00054\/tx960083qb00054_1","doi-asserted-by":"crossref","DOI":"10.1016\/0168-8278(95)80449-8","volume":"22","author":"Torgano G.","year":"1995","journal-title":"J. Hepatol."},{"key":"tx960083qb00055\/tx960083qb00055_1","doi-asserted-by":"crossref","DOI":"10.4049\/jimmunol.152.7.3245","volume":"152","author":"Ando K.","year":"1994","journal-title":"J. Immunol."},{"key":"tx960083qb00056\/tx960083qb00056_1","volume-title":"Trifluoroacetylation potentiates the humoral immune response to halothane in the guinea pig. Immunopharmacol. Immunotoxicol. 17, 201\u2212213","author":"Hastings K. L.","year":"1995"},{"key":"tx960083qb00057\/tx960083qb00057_1","first-page":"229","volume":"8","author":"Eliasson E.","year":"1995","journal-title":"ISSX Proc."},{"key":"tx960083qn00001\/tx960083qn00001_1","volume-title":"trifluoroacetylated","author":"Abbreviations TFA"}],"container-title":["Chemical Research in Toxicology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/pubs.acs.org\/doi\/pdf\/10.1021\/tx960083q","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,4,19]],"date-time":"2023-04-19T21:40:10Z","timestamp":1681940410000},"score":1,"resource":{"primary":{"URL":"https:\/\/pubs.acs.org\/doi\/10.1021\/tx960083q"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1996,1,1]]},"references-count":58,"journal-issue":{"issue":"7","published-print":{"date-parts":[[1996,1,1]]}},"alternative-id":["10.1021\/tx960083q"],"URL":"https:\/\/doi.org\/10.1021\/tx960083q","relation":{},"ISSN":["0893-228X","1520-5010"],"issn-type":[{"value":"0893-228X","type":"print"},{"value":"1520-5010","type":"electronic"}],"subject":[],"published":{"date-parts":[[1996,1,1]]}}}